Ryan Pelletier

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Venous Thromboembolism

Systematic Review

Top Venues

Endocrinology, diabetes & metabolism

Therapeutic advances in drug safety

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

University of Waterloo

Algoma University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Waterloo Sep 01 2018

Canada

Clinical Research Assistant :: Pharmacy

Education History

Algoma University Sep 01 2013 - Dec 01 2016

Canada

BSC :: Biology

Publications

Wajd Alkabbani, Ryan Pelletier, Michael A Beazely, Youssef Labib, Breanna Quan, John-Michael Gamble
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data. Drug safety 45 (3) (2022)
Ryan Pelletier, Kelvin Ng, Wajd Alkabbani, Youssef Labib, Nicolas Mourad, John-Michael Gamble
Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews. Therapeutic advances in drug safety 12 (2021)
Ryan Pelletier
Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (4) (2021)
Ryan Pelletier, Kelvin Ng, Wajd Alkabbani, Youssef Labib, Nicolas Mourad, John-Michael Gamble
The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews. Endocrinology, diabetes & metabolism 3 (3) (2020)